Atezolizumab Intravenous and Insulin degludec Subcutaneous
Determining the interaction of Atezolizumab Intravenous and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: atezolizumab
Brand name: Tecentriq
Synonyms: Atezolizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atezolizumab Intravenous-Insulin detemir
- Atezolizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Atezolizumab Intravenous-Insulin Detemir (Vials)
- Atezolizumab Intravenous-Insulin detemir Subcutaneous
- Atezolizumab Intravenous-Insulin glargine
- Atezolizumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Atgam
- Insulin degludec Subcutaneous-Atgam equine
- Insulin degludec Subcutaneous-Ativan
- Insulin degludec Subcutaneous-Ativan (Lorazepam Injection Solution)
- Insulin degludec Subcutaneous-Ativan (Lorazepam Tablets)
- Insulin degludec Subcutaneous-Ativan injection